Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,803 recalls · Class II, newest first

Class II · Moderate risk

Trelstar (triptorelin pamoate)

Labeling: Label Error On Declared Strength: Trelstar 11.25 mg labeled carton/kit contained a vial labeled as 3.75 mg instead of a vial being labeled as 11.25mg.

Terminated Labeling / mix-up Actavis Inc NDC 52544-154-02 D-1085-2014
Class II · Moderate risk

0.45% Sodium Chloride Injection USP

Labeling: Wrong Bar Code; Bar code scans as 0.15% Potassium Chloride in 0.9% Sodium Chloride (20 mEq K/liter).

Terminated Labeling / mix-up B. Braun Medical Inc NDC 0264-7802-00 D-407-2014
Class II · Moderate risk

Carisoprodol IV

Presence of Foreign Substance; heavy metals (chromium, titanium etc) and inactive components of the product were visually observed during routine stability testing.

Terminated Particulate / foreign matter Physicians Total Care, Inc. D-390-2014
Class II · Moderate risk

Dr. Sheffield Triple Antibiotic Ointment

Microbial Contamination of Non-Sterile Products: Elevated counts of gram positive rods were found during environmental testing

Terminated Microbial contamination Faria Limited LLC dba Sheffield Pharmaceuticals NDC 11527-162-47 D-1076-2014
Class II · Moderate risk

Phenylephrine Nasal 1% Spray

Microbial Contamination of Non Sterile Products: Tower Pharmacy is recalling the Phenylephrine Nasal Spray 1% because of possible microbial contamination.

Terminated Microbial contamination Tower Pharmacy and Compounding D-384-2014
Class II · Moderate risk

10%, Travasol

Lack of Assurance of Sterility; Drug product leaking from container therefore sterility cannot be assured

Terminated Sterility / contamination Baxter Healthcare Corp. D-368-2014
Class II · Moderate risk

Carisoprodol Tablets

Presence of Foreign Substance; heavy metals (chromium, titanium etc) and inactive components of the product were visually observed during routine stability testing

Terminated Particulate / foreign matter West-Ward Pharmaceutical Corp. NDC 0143-9749-10 D-367-2014
Class II · Moderate risk

Sumatriptan Succinate Injection

Lack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield.

Terminated Sterility / contamination GlaxoSmithKline, LLC. NDC 0781-3173-07 D-388-2014
Class II · Moderate risk

Imitrex STATdose System

Lack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield.

Terminated Sterility / contamination GlaxoSmithKline, LLC. NDC 0173-0479-00 D-387-2014
Class II · Moderate risk

Carbon Dioxide

Labeling: Not Elsewhere Classified; Due to an error in the manufacturing procedure, a cylinder in liquid withdrawal service was not marked Syphon Tube indicating liquid withdrawal and shipped as a gas withdrawal cylinder.

Terminated Labeling / mix-up Airgas Medical Services D-366-2014
Class II · Moderate risk

Clonazepam Tablets

Subpotent Drug: During routine stability testing one tablet was found with tablet weight below specification.

Terminated Wrong potency / content Actavis Elizabeth LLC NDC 0228-3005-11 D-1087-2014
Class II · Moderate risk

sertraline HCl tablets

Labeling: Incorrect or Missing Lot No. and/or Exp Date: Expiration date incorrectly reflects a 36 month shelf life, instead of the 24 month shelf life

Terminated Labeling / mix-up Greenstone LLC NDC 59762-4960-1 D-746-2014
Class II · Moderate risk

Nifedipine

Labeling: Incorrect or Missing Lot and/or Exp Date: Greenstone LLC is recalling Nifedipine Extended Release tablets (90mg). The expiration date on the package is 48 months instead of 36 months.

Terminated Labeling / mix-up Greenstone Llc NDC 59762-6692-8 D-737-2014
Class II · Moderate risk

PEGASPARGASE ONCASPAR Injection

Lack of Assurance of Sterility: Sigma-Tau PharmaSource, Inc. is conducting a voluntary recall of five lots of Oncaspar Injection, because of a crack under the crimp seal which caused a leak.

Terminated Sterility / contamination Sigma-Tau Pharmaceuticals, Inc. NDC 54482-301-01 D-736-2014
Class II · Moderate risk

Voriconazole 0.5mg/ml

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Terminated Sterility / contamination Natures Pharmacy & Compounding Center D-1145-2014
Class II · Moderate risk

Voriconazole 0.5mg/ml

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Terminated Sterility / contamination Natures Pharmacy & Compounding Center D-1144-2014
Class II · Moderate risk

Voriconazole 1% opthal

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Terminated Sterility / contamination Natures Pharmacy & Compounding Center D-1143-2014
Class II · Moderate risk

Vitamin D (Ergocalciferol)

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Terminated Sterility / contamination Natures Pharmacy & Compounding Center D-1142-2014
Class II · Moderate risk

Vit A (olive oil)

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Terminated Sterility / contamination Natures Pharmacy & Compounding Center D-1141-2014

Recalls by year